Tango Therapeutics Inc
(TNGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 42,069 | 36,527 | 24,860 | 37,042 | 7,656 |
| Gross Profit | 42,069 | 36,527 | 24,860 | 37,042 | 7,656 |
| Operating Expenses | 187,664 | 150,700 | 135,931 | 95,232 | 59,856 |
| Operating Income | -145,595 | -114,173 | -111,071 | -58,190 | -52,200 |
| Other Income | 15,501 | 12,563 | 2,949 | 247 | 228 |
| Pre-tax Income | -130,094 | -101,610 | -108,122 | -57,943 | -51,972 |
| Income Tax | 208 | 134 | 54 | 292 | N/A |
| Net Income Continuous | -130,302 | -101,744 | -108,176 | -58,235 | -51,972 |
| Net Income | $-130,302 | $-101,744 | $-108,176 | $-58,235 | $-51,972 |
| EPS Basic Total Ops | -1.19 | -1.08 | -1.23 | -0.94 | -1.63 |
| EPS Basic Continuous Ops | -1.19 | -1.08 | -1.23 | -0.94 | -1.63 |
| EPS Diluted Total Ops | -1.19 | -1.08 | -1.23 | -0.94 | -1.63 |
| EPS Diluted Continuous Ops | -1.19 | -1.08 | -1.23 | -0.94 | -1.63 |
| EPS Diluted Before Non-Recurring Items | -1.19 | -1.08 | -1.23 | -0.94 | N/A |
| EBITDA(a) | $-147,713 | $-115,152 | $-109,463 | $-57,293 | $-51,482 |